| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $141.1M | +31.5% |
| SG&A Expense | $62.2M | +28.8% |
| Operating Income | -$226.5M | -45.6% |
| Interest Expense | $1.9M | — |
| Pre-tax Income | -$225.3M | -43.7% |
| Income Tax | -$2.1M | -5415.4% |
| Net Income | -$223.2M | -42.3% |
| EPS (Basic) | -$1.72 | -16.2% |
| EPS (Diluted) | -$1.72 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.7M | +16.3% |
| Short-term Investments | $217.2M | -47.9% |
| Current Assets | $269.4M | -41.9% |
| Total Assets | $482.1M | -21.0% |
| Current Liabilities | $32.8M | -20.7% |
| Total Liabilities | $118.5M | +116.3% |
| Stockholders' Equity | $363.6M | -34.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$180.2M | -47.5% |
| Capital Expenditures | $84.6M | +46.3% |
| Investing Cash Flow | $114.5M | +124.1% |
| Financing Cash Flow | $71.9M | -81.7% |
| Free Cash Flow | -$264.8M | -47.1% |
| -16.2% |